🚀 VC round data is live in beta, check it out!
Cantourage Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cantourage Group and similar public comparables like Kezar Life Sciences, Mira Pharmaceuticals, THX Pharma, ProMIS Neurosciences and more.
Cantourage Group Overview
About Cantourage Group
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
Founded
2019
HQ
Employees
63
Website
Sectors
Financials (LTM)
EV
$52M
Cantourage Group Financials
Cantourage Group reported last 12-month revenue of $109M and EBITDA of $8M.
In the same LTM period, Cantourage Group generated $38M in gross profit, $8M in EBITDA, and $2M in net income.
Revenue (LTM)
Cantourage Group P&L
In the most recent fiscal year, Cantourage Group reported revenue of $27M and EBITDA of ($288K).
Cantourage Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $109M | XXX | $27M | XXX | XXX | XXX |
| Gross Profit | $38M | XXX | $9M | XXX | XXX | XXX |
| Gross Margin | 35% | XXX | 32% | XXX | XXX | XXX |
| EBITDA | $8M | XXX | ($288K) | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (1%) | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | (18%) | XXX | XXX | XXX |
| Net Profit | $2M | XXX | ($5M) | XXX | XXX | XXX |
| Net Margin | 2% | XXX | (18%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cantourage Group Stock Performance
Cantourage Group has current market cap of $53M, and enterprise value of $52M.
Market Cap Evolution
Cantourage Group's stock price is $4.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52M | $53M | (0.2%) | XXX | XXX | XXX | $-0.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCantourage Group Valuation Multiples
Cantourage Group trades at 0.5x EV/Revenue multiple, and 6.9x EV/EBITDA.
EV / Revenue (LTM)
Cantourage Group Financial Valuation Multiples
As of March 7, 2026, Cantourage Group has market cap of $53M and EV of $52M.
Equity research analysts estimate Cantourage Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cantourage Group has a P/E ratio of 30.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $53M | XXX | $53M | XXX | XXX | XXX |
| EV (current) | $52M | XXX | $52M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 6.9x | XXX | (180.7x) | XXX | XXX | XXX |
| EV/EBIT | 20.9x | XXX | (10.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.4x | XXX | 6.0x | XXX | XXX | XXX |
| P/E | 30.0x | XXX | (10.7x) | XXX | XXX | XXX |
| EV/FCF | 1030.1x | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cantourage Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cantourage Group Margins & Growth Rates
Cantourage Group's revenue in the last 12 month grew by 12%.
Cantourage Group's revenue per employee in the last FY averaged $1.7M.
Cantourage Group's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cantourage Group's rule of X is 36% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cantourage Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 292% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Growth | 37% | XXX | (2560%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 36% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.7M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cantourage Group Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Kezar Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Mira Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| THX Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| ProMIS Neurosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Moberg Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cantourage Group M&A Activity
Cantourage Group acquired XXX companies to date.
Last acquisition by Cantourage Group was on XXXXXXXX, XXXXX. Cantourage Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cantourage Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCantourage Group Investment Activity
Cantourage Group invested in XXX companies to date.
Cantourage Group made its latest investment on XXXXXXXX, XXXXX. Cantourage Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cantourage Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cantourage Group
| When was Cantourage Group founded? | Cantourage Group was founded in 2019. |
| Where is Cantourage Group headquartered? | Cantourage Group is headquartered in Germany. |
| How many employees does Cantourage Group have? | As of today, Cantourage Group has over 63 employees. |
| Is Cantourage Group publicly listed? | Yes, Cantourage Group is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Cantourage Group? | Cantourage Group trades under HIGH ticker. |
| When did Cantourage Group go public? | Cantourage Group went public in 2022. |
| Who are competitors of Cantourage Group? | Cantourage Group main competitors are Kezar Life Sciences, Mira Pharmaceuticals, THX Pharma, ProMIS Neurosciences. |
| What is the current market cap of Cantourage Group? | Cantourage Group's current market cap is $53M. |
| What is the current revenue of Cantourage Group? | Cantourage Group's last 12 months revenue is $109M. |
| What is the current revenue growth of Cantourage Group? | Cantourage Group revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Cantourage Group? | Current revenue multiple of Cantourage Group is 0.5x. |
| Is Cantourage Group profitable? | Yes, Cantourage Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cantourage Group? | Cantourage Group's last 12 months EBITDA is $8M. |
| What is Cantourage Group's EBITDA margin? | Cantourage Group's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Cantourage Group? | Current EBITDA multiple of Cantourage Group is 6.9x. |
| What is the current FCF of Cantourage Group? | Cantourage Group's last 12 months FCF is $51K. |
| What is Cantourage Group's FCF margin? | Cantourage Group's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Cantourage Group? | Current FCF multiple of Cantourage Group is 1030.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.